Clinical Trials Logo

Filter by:
NCT ID: NCT02748863 Completed - Psoriasis Clinical Trials

Study of Secukinumab With 2 mL Pre-filled Syringes

ALLURE
Start date: December 12, 2016
Phase: Phase 3
Study type: Interventional

The aim of the study was to demonstrate efficacy, safety and tolerability of 2 mL pre-filled syringe of 300 mg secukinumab in treatment of moderate to severe plaque psoriasis.

NCT ID: NCT02748382 Completed - Sepsis Clinical Trials

Fluids in Sepsis and Septic Shock

FISSH
Start date: August 18, 2016
Phase: Phase 2/Phase 3
Study type: Interventional

Despite evidence of the physiologic benefits and possible lower mortality associated with low chloride solutions, normal saline remains the most wildly used fluid in the world. Given uncertainty about the impact of lower chloride versus higher chloride solutions on mortality, it is unlikely that clinical practice will change without new and direct RCT evidence. Editorials published in leading critical care journals have called for RCT's to address this important clinical question. The proposed feasibility RCT will investigate the feasibility of a large-scale trial directly comparing low chloride versus normal chloride for resuscitation in septic shock on patient-important outcomes such as mortality and AKI.

NCT ID: NCT02748265 Completed - Clinical trials for Oxygenation During One Lung Ventilation

Nebulized Epoprostenol (FLOLAN) and Phenylephrine on One Lung Ventilation (OLV)

FLOLAN
Start date: March 2016
Phase: Phase 4
Study type: Interventional

This is a pilot study of a new use of Epoprostenol via inhalation (Epoprostenol is approved for intravenous use). The purpose of this study is to administered inhaled Epoprostenol and intravenous Phenylephrine to improve arterial oxygen tension during one-lung anesthesia either with volatile anesthesia (Sevoflurane) or with intravenous anesthesia (Propofol).

NCT ID: NCT02747043 Completed - Clinical trials for Lymphoma, Non-Hodgkin

Study to Assess if ABP798 is Safe & Effective in Treating Non Hodgkin Lymphoma Compared to Rituximab

JASMINE
Start date: May 25, 2016
Phase: Phase 3
Study type: Interventional

This was a randomized, double-blind, active-controlled, multiple-dose, clinical similarity study to evaluate the efficacy, pharmacokinetics, pharmacodynamics, safety, tolerability and immunogenicity of ABP 798 compared with rituximab in subjects with grade 1, 2, or 3a follicular B-cell NHL and low tumor burden. Subjects were randomized in a 1:1 ratio to receive a 375 mg/m^2 intravenous infusion of either ABP 798 or rituximab once weekly for 4 weeks followed by dosing at weeks 12 and 20.

NCT ID: NCT02746601 Completed - Primary Health Care Clinical Trials

My Health eSnapshot - A Preconception Health Research Study

Start date: February 2016
Phase: N/A
Study type: Interventional

The purpose of the research is to identify the prevalence of preconception health (PCH) risk factors in the Wellington-Dufferin-Guelph (WDG) catchment area and to determine whether or not a client-driven electronic preconception health risk assessment tool "My Health eSnapshot", for use during healthcare visits, will increase preconception health knowledge and behaviour change among women of reproductive age (15-49 years).

NCT ID: NCT02745275 Completed - Health Behavior Clinical Trials

Supporting Healthy Aging by Peer Education and Support

SHAPES
Start date: September 1, 2017
Phase: N/A
Study type: Interventional

Canadians are living longer than ever before. However, many in our society age with long term chronic medical conditions which have a major impact on their need for healthcare, their quality of life and well-being. Encouragement of lifestyle practices which promote healthy aging and self-management techniques to deal with chronic disease is important in improving peoples' well-being The purpose of this study is to study the impact of peer delivered education and support for seniors living in the community to see if training given to other seniors improves healthy ageing behaviours and their health literacy.

NCT ID: NCT02745236 Completed - Atrial Fibrillation Clinical Trials

The Effect of Nurse Practitioner Led-Care on Quality of Life in Patients With Atrial Fibrillation

Start date: July 31, 2016
Phase: N/A
Study type: Interventional

Atrial fibrillation (AF) is the most common heart rhythm disease characterized by an irregular heart rhythm of the top part (atria) of the heart. It may cause unpleasant symptoms as well as increases the person's risk of stroke and heart failure. With an ageing population, increasing rates of AF and limited access to specialists, new methods of care, like nurse practitioners (NP) need to be assessed to meet patient specific needs and provide sustainable care. The objective of the project is to evaluate the effect of Nurse Practitioner-led care in people with AF on their quality of life. The Canadian Healthcare system is overwhelmed, with increasing costs and wait times. Contributing to these issues, is AF is the most common arrhythmia accompanied with costly complications including stroke and heart failure. Currently family or emergency room physicians ask general cardiologists or specialized cardiologists, to provide care to patients with AF. Unfortunately, there is limited access to their services. NP's are nurses who have taken extra education at University to treat patients and prescribe medications. This research project involves an NP who has specialized training in AF patient management. By utilizing an NP to provide care for patients with AF, the investigators hope to improve patient's quality of life and satisfaction with care. This may also reduce complications of AF.

NCT ID: NCT02745080 Completed - Psoriatic Arthritis Clinical Trials

Efficacy of Secukinumab Compared to Adalimumab in Patients With Psoriatic Arthritis

EXCEED 1
Start date: April 3, 2017
Phase: Phase 3
Study type: Interventional

This was a randomized, double-blind, active controlled, multicenter, parallel-group study evaluating secukinumab monotherapy and adalimumab monotherapy in approximately 850 patients with active psoriatic arthritis (PsA) who are naïve to biologic therapy and are intolerant or having inadequate response to conventional disease modifying anti-rheumatic drugs (also known as non-biologic DMARDs).

NCT ID: NCT02744625 Completed - Shock Clinical Trials

Physiologic Study of Cerebral Perfusion

Start date: April 2016
Phase: Phase 4
Study type: Interventional

The aim of the study is to measure cerebral perfusion using MRI in healthy subjects (with and without sedation) and in vasopressor-dependent patients

NCT ID: NCT02744313 Completed - Adiposity Clinical Trials

MR Imaging of Fat Deposition in Adolescents With First Time Antipsychotic Use

Start date: April 2016
Phase:
Study type: Observational

This study will focus on a population of antipsychotic (AP) naïve adolescents and young adults and will measure fat accumulation in relation to exposure to atypical antipsychotic medications.